- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: HOE901-U300 (new formulation of insulin glargine)
Total 602 results
-
SanofiCompletedDiabetes Mellitus Type 2Germany
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Netherlands, Puerto Rico, Romania, Sweden
-
SanofiCompleted
-
SanofiCompletedType 2 Diabetes MellitusUnited States, South Africa, Canada, Czechia, Estonia, Finland, France, Germany, Hungary, Latvia, Mexico, Netherlands, Romania
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Finland, South Africa, Canada, Mexico, Chile, Spain, Russian Federation, France, Germany, Hungary, Portugal, Romania
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Lithuania, Netherlands, Puerto Rico, Romania, Slovakia, Sweden
-
SanofiCompletedType 1 Diabetes MellitusUnited States
-
SanofiCompleted
-
SanofiCompleted
-
SanofiCompletedType 1 Diabetes MellitusJapan
-
SanofiCompleted
-
SanofiCompleted
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Puerto Rico
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Australia, Spain, Korea, Republic of, Hungary, Mexico, Italy, Poland, Argentina, Canada, Colombia, France, Germany, Japan, Peru, Romania, Sweden, United Kingdom
-
SanofiCompletedType 2 Diabetes MellitusArgentina, Colombia, Egypt, Hong Kong, India, Indonesia, Lebanon, Malaysia, Peru, Philippines, Saudi Arabia, South Africa, Thailand, Turkey
-
SanofiCompletedType 2 Diabetes MellitusCanada
-
SanofiCompletedDiabetes Mellitus, Type 2France
-
SanofiCompletedType 2 Diabetes MellitusChina, Taiwan, Korea, Republic of
-
SanofiCompletedType I Diabetes MellitusBrazil
-
SanofiCompletedDiabetes Mellitus, Type 2Germany, Spain, Brazil, France, Ireland, Romania, United Kingdom
-
SanofiCompletedDiabetes Mellitus, Type 2Italy, Ireland, Spain, Greece, Finland, Romania, Brazil, United Kingdom, France, Switzerland
-
SanofiTerminatedType 2 Diabetes Mellitus | Renal ImpairmentUnited States, Czechia, Hungary, Poland, Serbia
-
SanofiActive, not recruiting
-
SanofiCompletedType 2 Diabetes MellitusGermany, United Kingdom
-
SanofiCompletedDiabetesPeru, Ukraine, Colombia, Egypt, India, Indonesia, Israel, Jordan, Kuwait, Lebanon, Mexico, Philippines, Russian Federation, Saudi Arabia, Singapore, Taiwan, Thailand, United Arab Emirates
-
SanofiCompleted
-
SanofiTerminated
-
SanofiCompletedType 1 Diabetes MellitusTurkey, Netherlands, Brazil, United States, Germany, Hungary, United Kingdom
-
SanofiCompleted
-
SanofiCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2Jordan
-
SanofiCompletedType 1 Diabetes MellitusGermany
-
SanofiCompleted
-
SanofiCompletedType 1 Diabetes MellitusGermany
-
SanofiCompletedDiabetes Mellitus, Type 2Israel, Czechia, Greece, Italy, United States, Bulgaria, Croatia, Denmark, France, Hungary, Romania, Serbia, Slovakia, Sweden, Switzerland, United Kingdom
-
SanofiCompletedType 1 Diabetes MellitusGermany
-
SanofiCompletedDiabetes Mellitus, Type 2Germany
-
SanofiCompletedType 2 DiabetesUnited States, Australia, Canada, Chile, Czech Republic, Denmark, Estonia, Hungary, Lithuania, Mexico, Netherlands, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine
-
SanofiCompletedType 2 DiabetesAustralia, Denmark, South Africa, Spain, Belgium, Russian Federation, Canada, Estonia, Hungary, Latvia, Mexico, United States, Chile, Czech Republic, France, Germany, Italy, Lithuania, Poland, Romania, Sweden, Ukraine, United Kingdom
-
SanofiCompletedType 1 Diabetes MellitusJapan, Spain, Germany, United States, France, Hungary, Poland, Russian Federation
-
SanofiCompleted
-
SanofiCompleted
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Argentina, Chile, Colombia, Germany, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Turkey
-
SanofiCompletedType 2 Diabetes MellitusChina, Korea, Republic of, Malaysia, Taiwan
-
SanofiCompletedDiabetes Mellitus, Type 2Australia, United Kingdom